Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gäken

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2011
Retroviral vectors as insertional mutagensJ Gäken, F Farzaneh
Cancer Gene Therapy|May 1, 1996
Novel costimulators in the immune gene therapy of cancerJ Galea-Lauri, F Farzaneh, J Gäken
Cancer Gene Therapy|April 19, 2000
Local versus systemic interleukin-2: tumor formation by wild-type and B7-1-positive murine melanoma cellsA L Barnard, F Farzaneh, J Gäken, et al.
Apoptosis : an International Journal on Programmed Cell Death|September 1, 2005
Apoptin: specific killer of tumor cells?M Tavassoli, L Guelen, B A Luxon, et al.
Gene Therapy|July 1, 1997
Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1W J Hirst, A Buggins, D Darling, et al.
Journal of Hepatology|June 1, 1997
Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infectionY Ma, G Gregorio, J Gäken, et al.
Gene Therapy|June 13, 2000
Low-speed centrifugation of retroviral vectors absorbed to a particulate substrate: a highly effective means of enhancing retroviral titreD Darling, C Hughes, J Galea-Lauri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cellsJ Galea-Lauri, D Darling, S U Gan, et al.
Blood|November 24, 1999
Effect of costimulation and the microenvironment on antigen presentation by leukemic cellsA G Buggins, N Lea, J Gäken, et al.
British Journal of Cancer|July 2, 1999
Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell linesM Sartor, H Steingrimsdottir, F Elamin, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2011
Retroviral vectors as insertional mutagensJ Gäken, F Farzaneh
Cancer Gene Therapy|May 1, 1996
Novel costimulators in the immune gene therapy of cancerJ Galea-Lauri, F Farzaneh, J Gäken
Cancer Gene Therapy|April 19, 2000
Local versus systemic interleukin-2: tumor formation by wild-type and B7-1-positive murine melanoma cellsA L Barnard, F Farzaneh, J Gäken, et al.
Apoptosis : an International Journal on Programmed Cell Death|September 1, 2005
Apoptin: specific killer of tumor cells?M Tavassoli, L Guelen, B A Luxon, et al.
Gene Therapy|July 1, 1997
Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1W J Hirst, A Buggins, D Darling, et al.
Journal of Hepatology|June 1, 1997
Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infectionY Ma, G Gregorio, J Gäken, et al.
Gene Therapy|June 13, 2000
Low-speed centrifugation of retroviral vectors absorbed to a particulate substrate: a highly effective means of enhancing retroviral titreD Darling, C Hughes, J Galea-Lauri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cellsJ Galea-Lauri, D Darling, S U Gan, et al.
Blood|November 24, 1999
Effect of costimulation and the microenvironment on antigen presentation by leukemic cellsA G Buggins, N Lea, J Gäken, et al.
British Journal of Cancer|July 2, 1999
Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell linesM Sartor, H Steingrimsdottir, F Elamin, et al.
Pageof 3